We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAA icon
826
PRA Group
PRAA
$698M
$433K ﹤0.01%
11,932
+178
+2% +$6.3K
SPYG icon
827
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.5B
$432K ﹤0.01%
10,320
NJR icon
828
New Jersey Resources
NJR
$6.11B
$430K ﹤0.01%
9,652
+73
+0.8% +$3.15K
WSM icon
829
Williams-Sonoma
WSM
$28B
$429K ﹤0.01%
11,684
-658
-5% -$22.9K
IGPT icon
830
Invesco AI and Next Gen Software ETF
IGPT
$1.13B
$428K ﹤0.01%
12,900
ABMD
831
DELISTED
Abiomed Inc
ABMD
$427K ﹤0.01%
2,511
-34
-1% -$6.3K
COO icon
832
Cooper Companies
COO
$13.9B
$426K ﹤0.01%
5,316
-1,904
-26% -$144K
INGN icon
833
Inogen
INGN
$174M
$426K ﹤0.01%
6,261
+1,252
+25% +$78.5K
IDXX icon
834
Idexx Laboratories
IDXX
$44.9B
$421K ﹤0.01%
1,618
-494
-23% -$130K
ACAD icon
835
Acadia Pharmaceuticals
ACAD
$4.42B
$418K ﹤0.01%
9,781
+2,266
+30% +$98.6K
ESE icon
836
ESCO Technologies
ESE
$8.22B
$418K ﹤0.01%
4,522
+3,242
+253% +$276K
USB.PRM
837
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$417K ﹤0.01%
15,143
SLGN icon
838
Silgan Holdings
SLGN
$5.02B
$416K ﹤0.01%
13,385
-11,545
-46% -$353K
GTLS
839
DELISTED
Chart Industries
GTLS
$414K ﹤0.01%
6,135
+1,330
+28% +$77.8K
AZTA icon
840
Azenta
AZTA
$1.32B
$413K ﹤0.01%
9,861
-726,479
-99% -$30.5M
BPMP
841
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$412K ﹤0.01%
26,426
+2,500
+10% +$37.1K
BHP icon
842
BHP
BHP
$213B
$411K ﹤0.01%
8,447
-301
-3% -$13.7K
WPX
843
DELISTED
WPX Energy, Inc.
WPX
$407K ﹤0.01%
29,661
+1,220
+4% +$13K
PRSP
844
DELISTED
Perspecta Inc. Common Stock
PRSP
$404K ﹤0.01%
15,354
+11,590
+308% +$309K
OLLI icon
845
Ollie's Bargain Outlet
OLLI
$4.26B
$403K ﹤0.01%
6,175
+285
+5% +$18.1K
PBA icon
846
Pembina Pipeline
PBA
$29B
$402K ﹤0.01%
10,850
+1,025
+10% +$36.7K
XYZ
847
Block Inc
XYZ
$49.3B
$402K ﹤0.01%
6,445
+200
+3% +$12.8K
FRC
848
DELISTED
First Republic Bank
FRC
$401K ﹤0.01%
3,421
-664
-16% -$71.7K
VMW
849
DELISTED
VMware, Inc
VMW
$397K ﹤0.01%
2,628
-833
-24% -$131K
AY
850
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$396K ﹤0.01%
15,025
+125
+0.8% +$3.12K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.